Our Publications
Below are some of the key scientific publications underpinning our work. We build on over a decade of work conducted by our scientific founders and their groups.
Clicking “View Publication” redirects you to the publication at source.
Our Publications
EASL 2024 Late Breaker: Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial
Journal of Hepatology
01/06/2024
EASL 2024 Poster: Developing a discovery platform for engineered macrophage cell therapies for end stage liver disease
Journal of Hepatology
01/06/2024
AASLD 2023 Poster: AN OPEN-LABEL PARALLEL-GROUP, PHASE II RANDOMISED CONTROLLED TRIAL OF AUTOLOGOUS MONOCYTE DERIVED MACROPHAGE INFUSION IN COMPENSATED CIRRHOSIS
AASLD Hepatology
13/11/2023